David A. Siegel Iradimed Corp Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Iradimed Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 35,300 shares of IRMD stock, worth $2.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,300

Previous 41,700 15.35%

Holding current value

$2.98 Million

Previous $2.49 Million 0.72%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$56.19 - $74.27 $359,616 - $475,328	-6,400 Reduced 15.35%	35,300 $2.51 Million
Q2 2025 Aug 14, 2025	BUY	$48.67 - $60.8 $282,286 - $352,640	5,800 Added 16.16%	41,700 $2.49 Million
Q1 2025 May 15, 2025	SELL	$51.44 - $62.67 $56,584 - $68,937	-1,100 Reduced 2.97%	35,900 $1.88 Million
Q4 2024 Feb 14, 2025	SELL	$48.3 - $57.35 $632,730 - $751,285	-13,100 Reduced 26.15%	37,000 $2.04 Million
Q3 2024 Nov 14, 2024	SELL	$43.23 - $50.29 $34,584 - $40,232	-800 Reduced 1.57%	50,100 $2.52 Million

Q2 2024 Aug 14, 2024	BUY	$40.36 - $44.7 $782,984 - $867,180	19,400 Added 61.59%	50,900 $2.24 Million
Q1 2024 May 15, 2024	BUY	$41.17 - $47.29 $74,106 - $85,122	1,800 Added 6.06%	31,500 $1.39 Million
Q4 2023 Feb 14, 2024	SELL	$37.31 - $47.47 $156,702 - $199,374	-4,200 Reduced 12.39%	29,700 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$43.28 - $50.3 $380,864 - $442,640	8,800 Added 35.06%	33,900 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$38.88 - $50.61 $346,032 - $450,429	8,900 Added 54.94%	25,100 $1.2 Million
Q1 2023 May 15, 2023	SELL	$28.48 - $42.14 $34,176 - $50,568	-1,200 Reduced 6.9%	16,200 $637,000
Q4 2022 Feb 14, 2023	SELL	$26.9 - $30.58 $18,830 - $21,406	-700 Reduced 3.87%	17,400 $492,000
Q3 2022 Nov 14, 2022	SELL	$29.42 - $42.25 $303,026 - $435,175	-10,300 Reduced 36.27%	18,100 $544,000
Q2 2022 Aug 15, 2022	SELL	$30.15 - $45.79 $223,110 - $338,846	-7,400 Reduced 20.67%	28,400 $964,000
Q1 2022 May 16, 2022	BUY	$36.01 - $53.14 $144,040 - $212,560	4,000 Added 12.58%	35,800 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $485,250 - $724,050	15,000 Added 89.29%	31,800 $1.47 Million
Q3 2021 Nov 15, 2021	BUY	$29.5 - $37.21 $495,600 - $625,128	16,800 New	16,800 $564,000
Q3 2019 Nov 14, 2019	SELL	$18.06 - $24.1 $222,137 - $296,430	-12,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$19.6 - $29.31 $45,080 - $67,413	-2,300 Reduced 15.75%	12,300 $252,000
Q1 2019 May 15, 2019	BUY	$23.58 - $28.43 $47,160 - $56,860	2,000 Added 15.87%	14,600 $410,000
Q4 2018 Feb 14, 2019	SELL	$20.63 - $34.04 $4,126 - $6,808	-200 Reduced 1.56%	12,600 $308,000
Q3 2018 Nov 14, 2018	BUY	$20.6 - $37.15 $263,680 - $475,520	12,800 New	12,800 $476,000

Others Institutions Holding IRMD

# of Institutions

190

Shares Held

6.74M

Call Options Held

Put Options Held

9.5K

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $1.06B
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account